Open an account

Lifeward

LFWD · NASDAQ

$6.06+$0.2431 (+4.18%)TodayMarket closed ·
Prev close $5.82

About LFWD

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The company is headquartered in Yokneam, Northern (Hazafon) and currently employs 81 full-time employees. The company went IPO on 2014-09-12. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Employees
81
Headquarters
Yokneam, Northern (HaZafon)
Listed
Sep 12, 2014
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
golifeward.com

LFWD key statistics

Market cap
17.16M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
9.94K
Volume
23.22K
Open price
$5.86
High today
$6.06
Low today
$5.64
52 Week high
$9.61
52 Week low
$4.14

Lifeward (LFWD) at a glance

Lifeward (LFWD) last traded at $6.06, with a market cap of 17.16M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.64 and $6.06. The current price is 7.4% above the day's low and 0.0% below its high.

Volume so far is 23.22K shares, above the average of 9.94K shares a day.

Over the past year Lifeward has ranged from $4.14 to $9.61, and now sits 35% of the way up that range.

Lifeward met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$1.46 per share against an estimate of -$1.37.

The average analyst price target is $20.40, 236.6% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $20.40
Low
$10.10
Now
$6.06
High
$31.50

LFWD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 8.8% on average.

  1. Q3 FY24: reported -$4.20 per share against an estimate of -$3.86
  2. Q4 FY24: reported -$7.44 per share against an estimate of -$6.28
  3. Q1 FY25: reported -$5.52 per share against an estimate of -$4.65
  4. Q2 FY25: reported -$6.96 per share against an estimate of -$3.73
  5. Q3 FY25: reported -$2.40 per share against an estimate of -$2.63
  6. Q4 FY25: reported -$3.60 per share against an estimate of -$1.10
  7. Q1 FY26: reported -$3.13 per share against an estimate of -$1.28
  8. Q2 FY26: reported -$1.46 per share against an estimate of -$1.37

LFWD news

  • Press releasePRNewswire

    Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

  • Press releaseGlobe Newswire

    Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

  • Press releasePRNewswire

    Oramed and Lifeward Announce Strategic Transaction

  • Preview: Rewalk Robotics's Earnings

  • Press releasePRNewswire

    MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

  • Avi Kapoor

    Crude Oil Rises Sharply; Torrid Holdings Shares Plunge

Similar companies

Companies in the same industry as Lifeward

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.